The COVID-19 Long Haul Foundation

Treatment, Referral & Educational Support for COVID-19 Illnesses & Vaccine Injury

Persistent attenuation of lymphocyte subsets after mass SARS-CoV-2 infection

Zhengqi Jiang ∙ Tichao Shan∙ Yucan Li ∙ Heyu Ni ∙ et. al., DOI: 10.1016/j.ijid.2025.108287 External Link Also available on ScienceDirect External Link Highlights SARS-CoV-2 causes lasting immune dysregulation for over 20 months. The impact of SARS-CoV-2 on lymphocytes was especially severe in patients […]

A GABA-receptor agonist reduces pneumonitis severity, viral load, and death rate in SARS-CoV-2-infected mice

Jide Tian1*Barbara J. Dillion2Jill Henley3et. al. Gamma-aminobutyric acid (GABA) and GABA-receptors (GABA-Rs) form a major neurotransmitter system in the brain. GABA-Rs are also expressed by 1) cells of the innate […]

The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches

Roxana Gheorghita1,2Iuliana Soldanescu3Andrei Lobiuc2 , et. al., Front. Immunol., 03 March 2024, Sec. Viral Immunology, Volume 15 – 2024 | https://doi.org/10.3389/fimmu.2024.1344086 The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has […]